UCLA scientists receive $1 million translational award to advance CAR T cell therapy for rare melanomas

Source: News Medical Sciences, August 2021

Scientists Dr. Cristina Puig-Saus and Dr. Daniel Shin from the UCLA Jonsson Comprehensive Cancer Center have received a $1 million Translational Research Award from the U.S. Department of Defense Melanoma Research Program to help advance the use of chimeric antigen receptor, or CAR, T cell therapy as a treatment for people with acral, mucosal and uveal melanomas.

READ THE ORIGINAL FULL ARTICLE